182 related articles for article (PubMed ID: 16893879)
1. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.
Roessler M; Rollinger W; Mantovani-Endl L; Hagmann ML; Palme S; Berndt P; Engel AM; Pfeffer M; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
Mol Cell Proteomics; 2006 Nov; 5(11):2092-101. PubMed ID: 16893879
[TBL] [Abstract][Full Text] [Related]
2. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
[TBL] [Abstract][Full Text] [Related]
3. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
[TBL] [Abstract][Full Text] [Related]
5. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
[TBL] [Abstract][Full Text] [Related]
6. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
[TBL] [Abstract][Full Text] [Related]
7. Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer.
Hamelin C; Cornut E; Poirier F; Pons S; Beaulieu C; Charrier JP; Haïdous H; Cotte E; Lambert C; Piard F; Ataman-Önal Y; Choquet-Kastylevsky G
FEBS J; 2011 Dec; 278(24):4845-59. PubMed ID: 21973086
[TBL] [Abstract][Full Text] [Related]
8. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
[TBL] [Abstract][Full Text] [Related]
9. Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis.
He Y; Mou Z; Li W; Liu B; Fu T; Zhao S; Xiang D; Wu Y
Int J Colorectal Dis; 2009 Nov; 24(11):1271-9. PubMed ID: 19597826
[TBL] [Abstract][Full Text] [Related]
10. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
[TBL] [Abstract][Full Text] [Related]
11. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.
Liu W; Ma Y; Huang L; Peng J; Zhang P; Zhang H; Chen J; Qin H
Mol Biol Rep; 2010 Oct; 37(7):3207-16. PubMed ID: 19842058
[TBL] [Abstract][Full Text] [Related]
12. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
Roessler M; Rollinger W; Palme S; Hagmann ML; Berndt P; Engel AM; Schneidinger B; Pfeffer M; Andres H; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
Clin Cancer Res; 2005 Sep; 11(18):6550-7. PubMed ID: 16166432
[TBL] [Abstract][Full Text] [Related]
13. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis.
Guo J; Hao J; Jiang H; Jin J; Wu H; Jin Z; Li Z
Cancer Lett; 2017 Feb; 386():161-167. PubMed ID: 27756569
[TBL] [Abstract][Full Text] [Related]
14. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract][Full Text] [Related]
15. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
[TBL] [Abstract][Full Text] [Related]
16. The prognosis value of proteasome activator subunit 3 expression in gastric cancer.
Chen ZM; Kai Z; Fang J; Chen Y; Fang YF; Hu SJ
J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36515625
[TBL] [Abstract][Full Text] [Related]
17. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry.
Katayama M; Nakano H; Ishiuchi A; Wu W; Oshima R; Sakurai J; Nishikawa H; Yamaguchi S; Otsubo T
Surg Today; 2006; 36(12):1085-93. PubMed ID: 17123137
[TBL] [Abstract][Full Text] [Related]
18. Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach.
Ma Y; Peng J; Huang L; Liu W; Zhang P; Qin H
Electrophoresis; 2009 Aug; 30(15):2591-9. PubMed ID: 19637221
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
20. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
